A cross-sectional study indicated that serum Corin levels were significantly higher in hypertension than in normal subjects, whereas animal experiments indicated that Corin was a type II transmembrane serine protease highly expressed in the heart that could activate natriuretic peptide and exhibit antihypertensive effects under physiological circumstances. This evidence concerns the gene CORIN and hypertensive disorder.